Transformational Hiring for Autoimmune Disease Patient Care

A clinical-stage biotechnology company was focused on the discovery and development of engineered T-cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.

Finding a Pathfinder for a Fibrotic Disease Fighter

​At a critical juncture in their journey, a leading biopharmaceutical company specializing in novel treatments for fibrotic diseases was poised to transition from late-stage development to market commercialization.